Literature DB >> 20846760

Synthesis and biological evaluation of 2-phenylthiazole-4-carboxamide derivatives as anticancer agents.

Alireza Aliabadi1, Fazel Shamsa, Seyed Nasser Ostad, Saeed Emami, Abbas Shafiee, Jamshid Davoodi, Alireza Foroumadi.   

Abstract

A series of substituted 2-phenylthiazole-4-carboxamide derivatives were synthesized as potential cytotoxic agents and evaluated against three human cancer cell lines including T47D (Breast cancer), Caco-2 (Colorectal cancer) and HT-29 (Colon cancer). The SAR of the arylacetamido pendent connected to the para-position of 2-phenylthiazole were explored. It was found that substitution at the 4-position by a methoxy group led to improvement of activity against Caco-2 cells while 2-methoxy substituent could maintain the high activity against HT-29 and T47D cell lines. Also, 3-fluoro analog showed good cytotoxic activity profile against all cell lines with IC(50) values less than 10 μg/mL.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846760     DOI: 10.1016/j.ejmech.2010.08.063

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  12 in total

1.  2-(3'-Indolyl)-N-arylthiazole-4-carboxamides: Synthesis and evaluation of antibacterial and anticancer activities.

Authors:  Mukund P Tantak; Jing Wang; Rajnish Prakash Singh; Anil Kumar; Kavita Shah; Dalip Kumar
Journal:  Bioorg Med Chem Lett       Date:  2015-08-06       Impact factor: 2.823

2.  Synthesis and Suzuki-Miyaura cross-coupling reactions of potassium Boc-protected aminomethyltrifluoroborate with aryl and hetaryl halides.

Authors:  Gary A Molander; Inji Shin
Journal:  Org Lett       Date:  2011-07-06       Impact factor: 6.005

3.  Comparison of Cytotoxic Activity of L778123 as a Farnesyltranferase Inhibitor and Doxorubicin against A549 and HT-29 Cell Lines.

Authors:  Saeed Ghasemi; Soodabeh Davaran; Simin Sharifi; Davoud Asgari; Ali Abdollahi; Javid Shahbazi Mojarrad
Journal:  Adv Pharm Bull       Date:  2013-02-07

4.  Synthesis and psychobiological evaluation of modafinil analogs in mice.

Authors:  Arezou Lari; Isaac Karimi; Hadi Adibi; Alireza Aliabadi; Loghman Firoozpour; Alireza Foroumadi
Journal:  Daru       Date:  2013-12-19       Impact factor: 3.117

5.  2-(4-Fluorophenyl)-N-phenylacetamide Derivatives as Anticancer Agents: Synthesis and In-vitro Cytotoxicity Evaluation.

Authors:  Alireza Aliabadi; Sajad Andisheh; Zahra Tayarani-Najaran; Mona Tayarani-Najaran
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

6.  Synthesis and Biological Investigation of some Novel Sulfonamide and Amide Derivatives Containing Coumarin Moieties.

Authors:  Mina Saeedi; Fereshteh Goli; Mohammad Mahdavi; Gholamreza Dehghan; Mohammad Ali Faramarzi; Alireza Foroumadi; Abbas Shafiee
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

7.  N-Phenyl-2-p-tolylthiazole-4-carboxamide derivatives: Synthesis and cytotoxicity evaluation as anticancer agents.

Authors:  Ahmad Mohammadi-Farani; Alireza Foroumadi; Monireh Rezvani Kashani; Alireza Aliabadi
Journal:  Iran J Basic Med Sci       Date:  2014-07       Impact factor: 2.699

8.  2-(2-(4-Benzoylpiperazin-1-yl)ethyl)isoindoline-1,3-dione derivatives: Synthesis, docking and acetylcholinesterase inhibitory evaluation as anti-alzheimer agents.

Authors:  Ahmad Mohammadi-Farani; Nasibeh Abdi; Alireza Moradi; Alireza Aliabadi
Journal:  Iran J Basic Med Sci       Date:  2017-01       Impact factor: 2.699

9.  Synthesis and evaluation of the cytotoxicity of a series of 1,3,4-thiadiazole based compounds as anticancer agents.

Authors:  Alireza Aliabadi; Elham Eghbalian; Amir Kiani
Journal:  Iran J Basic Med Sci       Date:  2013-11       Impact factor: 2.699

10.  Synthesis and In-vitro Cytotoxicity Assessment of N-(5-(Benzylthio)-1,3,4- thiadiazol-2-yl)-2-(4-(trifluoromethyl)phenyl)acetamide with Potential Anticancer Activity.

Authors:  Alireza Aliabadi; Zaman Hasanvand; Amir Kiani; Seyed Saber Mirabdali
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.